ask="4.91"
ask_size="9700"
average_daily_volume="63097"
bid="2.80"
bid_size="500"
book_value="1.19"
change="+0.00"
change_from_200_day_moving_average="-0.90"
change_from_50_day_moving_average="-0.34"
change_from_52_week_high="-3.09"
change_From_52_week_low="0.35"
change_in_percent="+0.00%"
close="3.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.40"
high_52_weeks="6.47"
last_trade_date="12/30/2016"
last_trade_price="3.38"
last_trade_size="3100"
last_trade_time="4:00pm"
low="3.20"
low_52_weeks="3.03"
market_capitalization="21.28M"
moving_average_200_day="4.28"
moving_average_50_day="3.72"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="3.31"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-21.09%"
percent_change_from_50_day_moving_average="-9.23%"
percent_change_from_52_week_high="-47.80%"
percent_change_from_52_week_low="+11.40%"
previous_close="3.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.84"
price_per_sales="23.50"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="3.84"
stock_exchange="NCM"
symbol="MBVX"
volume="92909"
weeks_range_52="3.03 - 6.47"
